306 related articles for article (PubMed ID: 26970828)
21. Synergistic antibacterial activity of silver with antibiotics correlating with the upregulation of the ROS production.
Zou L; Wang J; Gao Y; Ren X; Rottenberg ME; Lu J; Holmgren A
Sci Rep; 2018 Jul; 8(1):11131. PubMed ID: 30042429
[TBL] [Abstract][Full Text] [Related]
22. Strong and Nonspecific Synergistic Antibacterial Efficiency of Antibiotics Combined with Silver Nanoparticles at Very Low Concentrations Showing No Cytotoxic Effect.
Panáček A; Smékalová M; Kilianová M; Prucek R; Bogdanová K; Večeřová R; Kolář M; Havrdová M; Płaza GA; Chojniak J; Zbořil R; Kvítek L
Molecules; 2015 Dec; 21(1):E26. PubMed ID: 26729075
[TBL] [Abstract][Full Text] [Related]
23. [Antibacterial activity of beta-lactam antibiotics against extended-spectrum beta-lactamase producing bacteria].
Kuga A; Yano H; Okamoto R; Sato Y; Miyata A; Inoue M
Jpn J Antibiot; 1999 Sep; 52(9):585-94. PubMed ID: 10746193
[TBL] [Abstract][Full Text] [Related]
24. New Approach For Simvastatin As An Antibacterial: Synergistic Effect With Bio-Synthesized Silver Nanoparticles Against Multidrug-Resistant Bacteria.
Figueiredo EP; Ribeiro JM; Nishio EK; Scandorieiro S; Costa AF; Cardozo VF; Oliveira AG; Durán N; Panagio LA; Kobayashi R; Nakazato G
Int J Nanomedicine; 2019; 14():7975-7985. PubMed ID: 31632012
[TBL] [Abstract][Full Text] [Related]
25. Silver- and fluoride-containing mesoporous bioactive glasses versus commonly used antibiotics: Activity against multidrug-resistant bacterial strains isolated from patients with burns.
Gholipourmalekabadi M; Sameni M; Hashemi A; Zamani F; Rostami A; Mozafari M
Burns; 2016 Feb; 42(1):131-140. PubMed ID: 26603913
[TBL] [Abstract][Full Text] [Related]
26. Prediction of major antibiotic resistance in Escherichia coli and Klebsiella pneumoniae in Singapore, USA and China using a limited set of gene targets.
Ginn AN; Wiklendt AM; Zong Z; Lin RT; Teo JW; Tambyah PA; Peterson LR; Kaul K; Partridge SR; Iredell JR
Int J Antimicrob Agents; 2014 Jun; 43(6):563-5. PubMed ID: 24721234
[TBL] [Abstract][Full Text] [Related]
27. Antimicrobial susceptibility testing for Klebsiella pneumoniae isolates resistant to extended-spectrum beta-lactam antibiotics.
Jan IS; Hsueh PR; Teng LJ; Ho SW; Luh KT
J Formos Med Assoc; 1998 Oct; 97(10):661-6. PubMed ID: 9830274
[TBL] [Abstract][Full Text] [Related]
28. In vitro activity of avibactam (NXL104) in combination with β-lactams against Gram-negative bacteria, including OXA-48 β-lactamase-producing Klebsiella pneumoniae.
Aktaş Z; Kayacan C; Oncul O
Int J Antimicrob Agents; 2012 Jan; 39(1):86-9. PubMed ID: 22041508
[TBL] [Abstract][Full Text] [Related]
29. Laboratory identification, risk factors, and clinical outcomes of patients with bacteremia due to Escherichia coli and Klebsiella pneumoniae producing extended-spectrum and AmpC type β-lactamases.
Tsui K; Wong SS; Lin LC; Tsai CR; Chen LC; Huang CH
J Microbiol Immunol Infect; 2012 Jun; 45(3):193-9. PubMed ID: 22580086
[TBL] [Abstract][Full Text] [Related]
30. Pomegranate pericarp extract enhances the antibacterial activity of ciprofloxacin against extended-spectrum β-lactamase (ESBL) and metallo-β-lactamase (MBL) producing Gram-negative bacilli.
Dey D; Debnath S; Hazra S; Ghosh S; Ray R; Hazra B
Food Chem Toxicol; 2012 Dec; 50(12):4302-9. PubMed ID: 22982804
[TBL] [Abstract][Full Text] [Related]
31. Enhanced antibacterial effect of antibiotics in combination with silver nanoparticles against animal pathogens.
Smekalova M; Aragon V; Panacek A; Prucek R; Zboril R; Kvitek L
Vet J; 2016 Mar; 209():174-9. PubMed ID: 26832810
[TBL] [Abstract][Full Text] [Related]
32. Restoration of antibacterial activity of inactive antibiotics via combined treatment with a cyanographene/Ag nanohybrid.
Hochvaldová L; Panáček D; Válková L; Prucek R; Kohlová V; Večeřová R; Kolář M; Kvítek L; Panáček A
Sci Rep; 2022 Mar; 12(1):5222. PubMed ID: 35338239
[TBL] [Abstract][Full Text] [Related]
33. Extended spectrum beta-lactamase producing Escherichia coli and Klebsiella pneumoniae isolated in a rural hospital.
Basak S; Mallick SK; Bose S
J Indian Med Assoc; 2009 Dec; 107(12):855-8. PubMed ID: 20509468
[TBL] [Abstract][Full Text] [Related]
34. [Evolution of susceptibility to antibiotics of Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa and Acinetobacter baumanii, in a University Hospital Center of Beirut between 2005 and 2009].
Hamouche E; Sarkis DK
Pathol Biol (Paris); 2012 Jun; 60(3):e15-20. PubMed ID: 21719212
[TBL] [Abstract][Full Text] [Related]
35. In vitro effects of sulbactam combinations with different antibiotic groups against clinical Acinetobacter baumannii isolates.
Deveci A; Coban AY; Acicbe O; Tanyel E; Yaman G; Durupinar B
J Chemother; 2012 Oct; 24(5):247-52. PubMed ID: 23182043
[TBL] [Abstract][Full Text] [Related]
36. Bacterial effects and protein corona evaluations: crucial ignored factors in the prediction of bio-efficacy of various forms of silver nanoparticles.
Ashkarran AA; Ghavami M; Aghaverdi H; Stroeve P; Mahmoudi M
Chem Res Toxicol; 2012 Jun; 25(6):1231-42. PubMed ID: 22551528
[TBL] [Abstract][Full Text] [Related]
37. Transconjugation and genotyping of the plasmid-mediated AmpC beta-lactamase and extended-spectrum beta-lactamase genes in Klebsiella pneumoniae.
Shi WF; Zhou J; Qin JP
Chin Med J (Engl); 2009 May; 122(9):1092-6. PubMed ID: 19493446
[TBL] [Abstract][Full Text] [Related]
38. Antibiotic-resistance patterns and frequency of extended-spectrum beta-lactamase-producing isolates of Klebsiella pneumoniae in Tehran.
Feizabadi MM; Etemadi G; Yadegarinia D; Rahmati M; Shabanpoor S; Bokaei S
Med Sci Monit; 2006 Nov; 12(11):BR362-5. PubMed ID: 17072265
[TBL] [Abstract][Full Text] [Related]
39. Extended-spectrum beta-lactamase (ESBL) CTX-M-15-producing Escherichia coli and Klebsiella pneumoniae in Sofia, Bulgaria.
Markovska R; Schneider I; Keuleyan E; Bauernfeind A
Clin Microbiol Infect; 2004 Aug; 10(8):752-5. PubMed ID: 15301679
[TBL] [Abstract][Full Text] [Related]
40. [Activity of 9 beta-lactam antibiotics combined with clavulanic acid or sulbactam against the strains of broad-spectrum beta-lactamase (CTX-1) producing Enterobacteriaceae isolated at the Henri Mondor Hospital].
Legrand P; Soussy CJ; Orsoni A; Brickley X; Duval J
Pathol Biol (Paris); 1988 May; 36(5):425-9. PubMed ID: 3043338
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
